Gynecological Cancer

May 5, 2020

Study analyzes efficacy and safety of pembrolizumab combined with GX-188E, a DNA vaccine, in patients with advanced cervical cancer

The results were presented in the “Clinical Plenary: Immunotherapy Clinical Trials 1” session of AACR 2020 During the AACR Annual Meeting 2020, in one of the […]
May 4, 2020

Overall survival data released from Phase III EMBRACA Trial

Tazolaparib has shown no OS benefit in patients with advanced/metastatic negative HER2 breast cancer and germline BRCA1 / 2 mutations (gBRCAm) The Overall Survival (OS) results […]